Scottish Investment Giants Complete $14 Billion Merger

Aberdeen Asset Management and Standard Life combine to form investment titan

Scotland flag
The combined group will be one of the largest investment managers in the world.

Aberdeen Asset Management, which has its headquarters in the same city it is named for, and Edinburgh-headquartered Standard Life announced the completion of their merger on August 14.

The two firms had initially announced plans to combine in March 2017.

The new firm, Standard Life Aberdeen, administers £670 billion ($862 billion) while its new investment arm—Aberdeen Standard Investments—will have around £583 billion ($750 billion) in assets under management.

Both Keith Skeoch, CEO of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here